ICP clarity, long buying cycles, adoption-driven churn and per-door expansion: located, priced and ranked in a written report, reviewed and signed by the founder.
7 questions · 3 minutes · no email needed to see your grade
ICP blurred across 4 personas. Adoption at 31%.
Selling to agents, brokers, landlords, investors and PMs at once means no message fits anyone cleanly — and the funnel underperforms at every stage. Focused PropTech winners concentrate 60%+ of new revenue on one primary persona before expanding.
CRE and multifamily buying committees, pilots and procurement stretch deals for months. Every extra week of cycle is CAC you've already paid sitting idle before it pays back. Cycle compression of even one stage recovers significant pipeline velocity.
A real-estate buyer who signs but never adopts churns quietly at renewal — and drags expansion revenue down with them. Accounts that don't hit a 30-day adoption milestone renew at a fraction of the rate of those that do.
Every tier follows the same path. Only the depth of the diagnosis changes with the price.
Choose the tier that fits your ARR, or take the free grade first and let it point you to one.
2 minutes18 questions on pricing, retention and pipeline. Anything you don't have is flagged in the report, never guessed.
About 15 minutesEvery leak located, priced and ranked, with the fixes in order, reviewed and signed by the founder.
18–24 hours · Starter 48–72Four inputs, one directional estimate from published benchmarks. It is a preview, not the diagnostic.
Directional only. The diagnostic replaces every estimate with a figure from your own numbers.
Which of the five PropTech personas — agent, broker, landlord, investor, PM — has the best economics for you, and where is GTM spend misallocated?
Where exactly does your sales cycle stall — discovery, pilot, committee, procurement — and what lever compresses each stage?
What is your 30-day activation rate, and which accounts are churn-risk before they reach renewal?
Are you pricing on seats while value scales with doors, GMV, or transactions? The gap is usually $150K-$500K/yr in untouched expansion revenue.
Are portfolio growth, door additions, and GMV milestones wired into automatic expansion triggers — or left uncaptured at renewal?
These five are read first. Each tier below states exactly how far the diagnosis goes beyond them.
Pick the tier that matches your ARR. Every diagnostic is reviewed and signed by the founder and delivered in writing.
The 3 most painful PropTech frameworks on your real numbers — plus the ICP-Clarity Map and the SOC 2 / CCPA enterprise-readiness map. Sharp first read before the full diagnostic. vs $15K–$50K specialist consultants charge for the SOC 2 / CCPA scoping alone.
Seed to Series A. The full board-grade PropTech diagnosis — dollar-quantified, ICP-clear, priced to your stage. About 0.5% of the ~$675K–$1.35M a sub-$5M-ARR PropTech is typically bleeding.
1% gain ≈ up to $10K/yr at your scale
Seed to Series A. The full board-grade PropTech diagnosis — dollar-quantified, ICP-clear, priced to your stage. About 0.5% of the ~$675K–$1.35M a sub-$5M-ARR PropTech is typically bleeding.
1% gain ≈ $10K–$30K/yr at your scale
Series A to B. The full diagnosis plus a deeper pass, sized to a scaling PropTech team. About 0.5% of the ~$1.35M–$2.25M a $5M–$25M-ARR PropTech is typically bleeding.
1% gain ≈ $30K–$150K/yr at your scale
Series B+. Everything in Growth, at the depth a mature PropTech org and its board needs. About 0.5% of the ~$3M+ a $25M–$50M-ARR PropTech is typically bleeding.
1% gain ≈ $150K–$500K/yr at your scale
A board-grade PDF: 22 pages for the Founder tier (5 for the Starter). Cover, exec summary, ICP-Clarity Map, 18-framework scorecard, dollar-quantified findings, sales-cycle diagnosis vs PropTech benchmark, pricing model verdict, 30-day priority queue.
PMP®- and RMP®-certified senior planning engineer (BEng Hons). Every diagnostic is personally run, reviewed and signed by me — no outsourced analysts, no call-booking funnel. The methodology is public: judge the teardowns before you spend a dollar.
Judge the method before you buy. Public teardowns:
If a finding doesn't hold up, a number needs sharpening or an input is missing, we rework the diagnostic at no charge until you can act on it. All sales are final; the rework is the guarantee.
Start with the free grade. When you're ready, the diagnostic puts a dollar figure and a fix on every leak.